{"id":17522,"date":"2026-02-24T00:07:07","date_gmt":"2026-02-24T00:07:07","guid":{"rendered":"https:\/\/www.europesays.com\/be-fr\/17522\/"},"modified":"2026-02-24T00:07:07","modified_gmt":"2026-02-24T00:07:07","slug":"une-vingtaine-de-lots-de-doliprane-24-suspension-buvable-rappeles","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/be-fr\/17522\/","title":{"rendered":"Une vingtaine de lots de Doliprane 2,4% suspension buvable rappel\u00e9s"},"content":{"rendered":"<p>Le laboratoire Opella Healthcare France, en accord avec l\u2019ANSM, proc\u00e8de au rappel de 27 lots de Doliprane 2,4% (parac\u00e9tamol), suspension buvable. En cause\u00a0: un d\u00e9faut de qualit\u00e9 identifi\u00e9 sur certaines des pipettes fournies avec le flacon, dont les graduations sont susceptibles de s\u2019effacer progressivement apr\u00e8s un rin\u00e7age \u00e0 l\u2019eau ti\u00e8de ou chaude. Au risque d\u2019entra\u00eener un potentiel surdosage en parac\u00e9tamol chez les nourrissons et jeunes enfants.<\/p>\n<p>\u00ab\u00a0Les patients qui ont une bo\u00eete provenant d\u2019un des lots concern\u00e9s sont invit\u00e9s \u00e0 la rapporter \u00e0 leur pharmacie pour qu\u2019elle leur soit remplac\u00e9e gratuitement\u00a0\u00bb, <a href=\"https:\/\/ansm.sante.fr\/actualites\/doliprane-2-4-paracetamol-suspension-buvable-rappel-de-certains-lots-en-raison-de-leffacement-des-graduations-des-pipettes#\" rel=\"nofollow noopener\" target=\"_blank\">indique l\u2019ANSM<\/a>, qui pr\u00e9cise par ailleurs que l\u2019origine du d\u00e9faut a \u00e9t\u00e9 identifi\u00e9e et corrig\u00e9e.<\/p>\n<p>Au total, 27 lots sont concern\u00e9s par ce rappel, distribu\u00e9s entre le 12 novembre 2025 et le 3 f\u00e9vrier 2026\u00a0:<\/p>\n<p>L033 (EXP 08\/2027) ;<br \/>\nL034 (EXP 08\/2027) ;<br \/>\nL035 (EXP 08\/2027) ;<br \/>\nL036 (EXP 08\/2027) ;<br \/>\nL037 (EXP 09\/2027) ;<br \/>\nL038 (EXP 09\/2027) ;<br \/>\nL039 (EXP 09\/2027) ;<br \/>\nL040 (EXP 09\/2027) ;<br \/>\nL041 (EXP 09\/2027) ;<br \/>\nL042 (EXP 09\/2027) ;<br \/>\nL043 (EXP 09\/2027) ;<br \/>\nL044 (EXP 09\/2027) ;<br \/>\nL045 (EXP 09\/2027) ;<br \/>\nL046 EXP (09\/2027) ;<br \/>\nL047 (EXP 09\/2027) ;<br \/>\nL048 (EXP 09\/2027) ;<br \/>\nL049 (EXP 09\/2027) ;<br \/>\nL050 (EXP 10\/2027) ;<br \/>\nL051 (EXP 10\/2027) ;<br \/>\nL053 (EXP 10\/2027) ;<br \/>\nL054 (EXP 10\/2027) ;<br \/>\nL055 (EXP 10\/2027) ;<br \/>\nL056 (EXP 10\/2027) ;<br \/>\nL057 (EXP 10\/2027) ;<br \/>\nL058 (EXP 10\/2027) ;<br \/>\nL061 (EXP 10\/2027) ;<br \/>\nL062 (EXP 10\/2027).<\/p>\n<p>Aux pharmaciens, l\u2019Agence demande de v\u00e9rifier les num\u00e9ros de lots de Doliprane 2,4%, suspension buvable qu\u2019ils ont en stock, mentionn\u00e9s sur le flacon ou au dos de la bo\u00eete, de contacter les patients auxquels ils auraient dispens\u00e9 une boite concern\u00e9e pour les informer de la proc\u00e9dure d\u2019\u00e9change \u00e0 titre gratuit et de les sensibiliser au risque de surdosage s\u2019ils utilisent une pipette dont les graduations sont effac\u00e9es, ou une pipette provenant d\u2019un autre m\u00e9dicament.<\/p>\n<p>En cas de suspicion de sympt\u00f4mes de surdosage (naus\u00e9es, vomissements, anorexie, p\u00e2leur ou douleurs abdominales), les patients doivent \u00eatre orient\u00e9s vers un m\u00e9decin.<\/p>\n","protected":false},"excerpt":{"rendered":"Le laboratoire Opella Healthcare France, en accord avec l\u2019ANSM, proc\u00e8de au rappel de 27 lots de Doliprane 2,4%&hellip;\n","protected":false},"author":2,"featured_media":17523,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[82],"tags":[12,13,18,17,10588,86,10589,10590,87],"class_list":{"0":"post-17522","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-be","9":"tag-be-fr","10":"tag-belgique","11":"tag-belgium","12":"tag-doliprane","13":"tag-health","14":"tag-rappel","15":"tag-rappel-de-lot","16":"tag-sante"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts\/17522","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/comments?post=17522"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts\/17522\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/media\/17523"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/media?parent=17522"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/categories?post=17522"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/tags?post=17522"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}